drugset / Trial / NCT04501718
Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
NaSingle-groupOpen-labelTreatment
Summary
This study is a prospective single-center clinical study, which aims to observe and evaluate the efficacy and safety of apatinib combined with temozolomide and oral etoposide in the treatment of recurrent medulloblastoma in children.
Timeline
- Start
- 2020-10-28
- Primary completion
- 2025-08-31
- Completion
- 2025-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etoposide | Small molecule | — | Oral |
| Subject | Rivoceranib | Small molecule | 250 mg | Oral |
| Subject | Temozolomide | Small molecule | — | — |